Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
2021 · Nature Communications · 125 citations
https://doi.org/10.1038/s41467-021-25432-7
D
Derek Clouthier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.4K
Citations
15
h-index
17
i10-index
Derek Clouthier is an academic researcher from AstraZeneca (Canada). The author has contributed to research in topics: Immune Cell Function and Interaction & Immunotherapy and Immune Responses & Ovarian cancer diagnosis and treatment. The author has an h-index of 15, co-authored 45 publications.
Papers by this author
worksLandscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
2018 · Genome Medicine · 107 citations
https://doi.org/10.1186/s13073-018-0590-x
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient
2024 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-024-45449-y
GITR<sup>-/-</sup> mice have defective follicular helper CD4 T cell responses following LCMV cl 13 infection.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1004517.g005
Additional file 13: of Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7285865
Additional file 9: of An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7843673
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat